問卷

TPIDB > 臨床試驗主持人

臨床試驗主持人


國立台灣大學醫學院附設醫院 (在職)

外科

消化內科

內科

血液腫瘤科

更新時間:2023-09-19

何明志Ho, Ming-Chih
  • 計畫主持人
  • 執行臨床試驗年資 17 年 9 個月

發表文獻

22

1

Shao, Y. Y., Wang, S. Y., Lin, S. M., Diag, G., & Systemic Therapy, G. (2021). Management consensus guideline for hepatocellular carcinoma: 2020 update on surveillance, diagnosis, and systemic treatment by the Taiwan Liver Cancer Association and the Gastroenterological Society of Taiwan. Journal of the Formosan Medical Association, 120(4), 1051-1060. https://doi.org/10.1016/j.jfma.2020.10.031

2

Hsiao, C. Y., Ho, M. C., Ho, C. M., Wu, Y. M., Lee, P. H., & Hu, R. H. (2021). Long-Term Tacrolimus Blood Trough Level and Patient Survival in Adult Liver Transplantation. Journal of Personalized Medicine, 11(2), Article 90. https://doi.org/10.3390/jpm11020090

3

Lin, C. H., Ho, C. M., Wu, C. H., Liang, P. C., Wu, Y. M., Hu, R. H., Lee, P. H., & Ho, M. C. (2020). Minimally invasive surgery versus radiofrequency ablation for single subcapsular hepatocellular carcinoma <= 2 cm with compensated liver cirrhosis. Surgical Endoscopy and Other Interventional Techniques, 34(12), 5566-5573. https://doi.org/10.1007/s00464-019-07357-x

4

Lu, C. Y., Chen, C. L., Ho, C. M., Hsiao, C. Y., Wu, Y. M., Ho, M. C., Lee, P. H., & Hu, R. H. (2020). Dynamic Prognostication in Transplant Candidates with Acute-on-Chronic Liver Failure. Journal of Personalized Medicine, 10(4), Article 230. https://doi.org/10.3390/jpm10040230

5

Wu, M. H., Chen, K. Y., Shih, S. R., Ho, M. C., Tai, H. C., Chang, K. J., Chen, A., & Chen, C. N. (2020). Multi-Reader Multi-Case Study for Performance Evaluation of High-Risk Thyroid Ultrasound with Computer-Aided Detection. Cancers, 12(2), Article 373. https://doi.org/10.3390/cancers12020373

6

Hsiao, C. Y., Hu, R. H., Ho, C. M., Wu, Y. M., Lee, P. H., & Ho, M. C. (2020). Surgical resection versus radiofrequency ablation for Barcelona Clinic Liver Cancer very early stage hepatocellular carcinoma: long-term results of a single-center study. American Journal of Surgery, 220(4), 958-964. https://doi.org/10.1016/j.amjsurg.2020.03.017

7

Su, S. T., Ho, M. C., Yen, J. Y., & Chen, Y. Y. (2020). Featured Surface Matching Method for Liver Image Registration. Ieee Access, 8, 59723-59731. https://doi.org/10.1109/access.2020.2983325

8

Shen, Y. C., Hsu, C. L., Jeng, Y. M., Ho, M. C., Ho, C. M., Yeh, C. P., Yeh, C. Y., Hsu, M. C., Hu, R. H., & Cheng, A. L. (2020). Reliability of a single-region sample to evaluate tumor immune microenvironment in hepatocellular carcinoma. Journal of Hepatology, 72(3), 489-497. https://doi.org/10.1016/j.jhep.2019.09.032

9

Zhou, Z. H., Fang, J., Cristea, A., Lin, Y. H., Tsai, Y. W., Wan, Y. L., Yeow, K. M., Ho, M. C., & Tsui, P. H. (2020). Value of homodyned K distribution in ultrasound parametric imaging of hepatic steatosis: An animal study. Ultrasonics, 101, Article 106001. https://doi.org/10.1016/j.ultras.2019.106001

10

Ho, C. M., Hu, R. H., Wu, Y. M., Ho, M. C., & Lee, P. H. (2020). Cross-Match as an Immuno-Oncological Risk Factor for Hepatocellular Carcinoma Recurrence and Inferior Survival After Living Donor Liver Transplantation: A Call for Further Investigation. Clinical Medicine Insights-Oncology, 14, Article 1179554920968774. https://doi.org/10.1177/1179554920968774
1 2 3